AtriCure, Inc.
ATRC Healthcare Medical Instruments & Supplies
AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024. In the quarter to June 2026, revenue grew 12.8%, EPS grew 238.5%, free cash flow fell 2.79% and total debt fell 4.43%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
Follow ATRC
AtriCure, Inc. (ATRC) P/E ratio
As of 16 October 2026, AtriCure, Inc. (ATRC) trades at a P/E ratio of 259×. Over the past ten years it has ranged from 0.0× (June 2026) to 281× (September 2026); the current reading is higher than 99% of that period. That is above the Medical Instruments & Supplies industry median of 33.8× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 62.6× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 129× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| PLSE Pulse Biosciences, Inc compare | n/m |
| KMTS Kestra Medical Technologies, Ltd. compare | n/m |
| XRAY DENTSPLY SIRONA Inc. compare | n/m |
| LMAT LeMaitre Vascular, Inc. compare | 27.9× |
| STVN Stevanato Group S.p.A. compare | 33.8× |
| NVST Envista Holdings Corporation compare | 38.8× |
| ICUI ICU Medical, Inc. compare | 136× |
| ATRC AtriCure, Inc. | 259× |
| WRBY Warby Parker Inc. compare | 334× |
| Medical Instruments & Supplies industry median | 33.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)